Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2026-03-09 @ 2:36 AM
Study NCT ID:
NCT02505568
Status:
COMPLETED
Last Update Posted:
2019-10-17
First Post:
2015-06-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease
Sponsor:
Janssen Korea, Ltd., Korea
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR107121
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None